Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 14/20 | 0.56 |
| ▸ | CA1 | P00915 | 13/20 | 0.52 |
| ▸ | MMP1 | P03956 | 4/20 | 0.52 |
| ▸ | MMP2 | P08253 | 4/20 | 0.52 |
| ▸ | MMP9 | P14780 | 4/20 | 0.52 |
| ▸ | MMP8 | P22894 | 4/20 | 0.52 |
| ▸ | MMP13 | P45452 | 4/20 | 0.52 |
| ▸ | F2 | P00734 | 4/20 | 0.46 |
| ▸ | PRSS1 | P07477 | 4/20 | 0.46 |
| ▸ | PRSS2 | P07478 | 4/20 | 0.46 |
| ▸ | PRSS3 | P35030 | 4/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL585308 | 1.00 | CA2 (0.56) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL302264 | 1.00 | CA2 (0.56) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL584864 | 1.00 | CA2 (0.56) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL585171 | 1.00 | CA2 (0.56) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL3838335 | 1.00 | CA2 (0.56) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL7660482 | 1.00 | CA2 (0.56) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL73684 | 0.97 | CA2 (0.52) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL6898759 | 0.94 | CA2 (0.50) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL13684270 | 0.91 | CA2 (0.43) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL11788241 | 0.91 | CA2 (0.43) | CA2CA1MMP1MMP2MMP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 327 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4646060-A9 | SOLAR CELL AND MANUFACTURING METHOD THEREFOR, AND PHOTOVOLTAIC MODULE | Longi Green Energy Technology Co., Ltd. (CN) | 2025-12-17 | — | — | EP | claimed |
| EP-4646060-A1 | SOLAR CELL AND MANUFACTURING METHOD THEREFOR, AND PHOTOVOLTAIC MODULE | Longi Green Energy Technology Co., Ltd. (CN) | 2025-11-05 | — | — | EP | claimed |
| CN-119816074-A | Perovskite light absorption layer, preparation method and perovskite solar cell | 仁烁光能(苏州)有限公司 | 2025-04-11 | — | — | CN | claimed |
| CN-119650817-A | Electrochemical device and electronic device | 宁德新能源科技有限公司 | 2025-03-18 | — | — | CN | claimed |
| CN-116516694-B | Short fluorocarbon chain based amphiphobic coating and preparation method and application thereof | 天津理工大学 | 2025-01-28 | — | — | CN | claimed |
| CN-116178223-B | Belzutifan and preparation method of intermediate thereof | 上海皓鸿生物医药科技有限公司 | 2024-12-03 | — | — | CN | claimed |
| CN-118615632-A | Preparation method of fire extinguishing agent special for efficient cooling and re-combustion inhibiting lithium battery | 中科永安(铜陵)科技有限公司 | 2024-09-10 | — | — | CN | claimed |
| CN-118530658-A | High-temperature-resistant photo-curing silicon-based release agent and preparation method thereof | 苏州帝联庆新材料科技有限公司 | 2024-08-23 | — | — | CN | claimed |
| CN-116103021-B | Foaming agent for oil-based drilling fluid and preparation method and application thereof | 中石化石油工程技术服务有限公司 | 2024-08-16 | — | — | CN | claimed |
| CN-116103024-B | Oil-based foaming agent and preparation method thereof | 中石化石油工程技术服务有限公司 | 2024-07-12 | — | — | CN | claimed |
| US-10483590-B2 | Electrolyte for lithium ion battery and lithium ion battery including the same | OPTIMUM BATTERY CO., LTD. (CN) | 2019-11-19 | — | — | US | claimed |
| US-20180212276-A1 | ELECTROLYTE FOR LITHIUM ION BATTERY AND LITHIUM ION BATTERY INCLUDING THE SAME | Shenzhen Anding New Energy Technology Development Co., Ltd. (CN) | 2018-07-26 | — | — | US | claimed |
| EP-3352276-A1 | ELECTROLYTE FOR LITHIUM ION BATTERY AND LITHIUM ION BATTERY INCLUDING THE SAME | Optimum Battery Co., Ltd. (CN) | 2018-07-25 | — | — | EP | claimed |
| US-20050171126-A1 | Process for the production of purine nucleoside compounds | AJINOMOTO CO., INC. (JP) | 2005-08-04 | — | — | US | claimed |
| US-20050070647-A1 | Flame retardant composition process for producing the same, flame-retardant resin composition, and molded object thereof | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2005-03-31 | — | — | US | claimed |
| EP-1462503-A1 | FLAME RETARDANT COMPOSITION, PROCESS FOR PRODUCING THE SAME, FLAME-RETARDANT RESIN COMPOSITION, AND MOLDED OBJECT THEREOF | DAICEL CHEMICAL INDUSTRIES, Ltd. (JP) | 2004-09-29 | — | — | EP | claimed |
| EP-1131270-B1 | PROCESS FOR CONVERTING AN ALCOHOL TO THE CORRESPONDING FLUORIDE | 3M INNOVATIVE PROPERTIES CO (US) | 2004-04-07 | — | — | EP | claimed |
| EP-1131270-A1 | PROCESS FOR CONVERTING AN ALCOHOL TO THE CORRESPONDING FLUORIDE | 3M Innovative Properties Company (US) | 2001-09-12 | — | — | EP | claimed |
| US-6248889-B1 | FORMING MIXTURE COMPRISING AT LEAST ONE FLUORINATED, SATURATED ALIPHATIC OR ALICYCLIC SULFONYL FLUORIDE AND AT LEAST ONE PRIMARY OR SECONDARY ALCOHOL, ADDING MOLAR EXCESS OF STRONG, APROTIC, NON-NUCLEOPHILIC HINERED ORGANIC BASE | 3M INNOVATIVE PROPERTIES COMPANY | 2001-06-19 | — | — | US | claimed |
| WO-2000031003-A1 | PROCESS FOR CONVERTING AN ALCOHOL TO THE CORRESPONDING FLUORIDE | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2000-06-02 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050171126-A1 | Process for the production of purine nucleoside compounds | PNP, NUDT1, UMPS | CA2 2556/4885CA1 1904/4885MMP1 2623/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.